The global durable medical equipment (DME) market is expected to
register a CAGR of about 7% during the forecast period, 2018-2023.

Over the last decade, there has been a rise in the prevalence of several
chronic diseases, which in several cases need long hospital stays. Some
of the major chronic diseases include cancer, kidney failure, and heart
diseases, etc. The World Health Organization (WHO) states that
approximately 30% (nearly 18 million people) of the global deaths can be
attributed to cardiovascular diseases. Monitoring and therapeutics
devices play major roles in the management and diagnosis of several
heart diseases, such as congenital heart diseases, valvular diseases,
and arterial stiffness, and the assessment of cardiac electrophysiology
and cardiovascular health.

The need for skilled professionals and improved facilities is increasing
each year both in developed and emerging markets.

The Asia-Pacific region is poised to register the fastest growth rate
due to the increasing R&D expenditure by governments and private
companies in healthcare. Owing to a diversified patient population, the
risk of life-threatening disorders in the region is high. Countries,
such as China, Japan, and India, have witnessed an increased economic
growth over the past five years which has helped develop improved
healthcare infrastructure, thus, driving the growth of this market. The
demographics in the emerging markets in the Asia-Pacific region is
improving gradually.